[Analysis of listed stocks on September 21: The promotion rate of listed stocks exceeds 60%. The "Hua" generation stocks have a large-scale daily limit] Today, a total of 103 stocks hit the daily limit, and the total number of listed stocks is 21, including 8 stocks with three consecutive boards or above. On the previous trading day, there were a total of 12 listed stocks, and the promotion rate of listed stocks was 66.67% (excluding ST shares and delisted stocks). In terms of individual stocks, more than 4,500 stocks in the market rose, exceeding the daily limit of 100 stocks. Short-term sentiment continued to rise. Metaphysics speculation prevailed. More than 30 "Hua" stocks hit the daily limit, including Hua Porcelain Co., Ltd. 5 consecutive boards, Inner Mongolia Xinhua 4 consecutive boards, Huasuan Technology, Huafang Co., Ltd., Nanhua Biotech 3 consecutive boards, Xinhua Wenxuan and Huajin Capital 2 consecutive boards. The "Sheep" generation is also active, Sanyangma 2 consecutive boards, Ocean King 4 days and 2 boards. In terms of sectors, the real estate sector rose sharply again, with World Union Bank having 4 consecutive boards, Greenland Holdings having 2 consecutive boards, Vanke A once touching 2 consecutive boards, Huayuan Holdings, Shenzhen Huafa A, I Love My Home and other stocks hitting the daily limit; pharmaceutical stocks broke out across the board, with innovative drugs and AI pharmaceuticals leading the gains, and Nanhua Biotech 3 consecutive boards, Ruikang Pharmaceutical 2 consecutive boards, Baihua Pharmaceutical 3 days and 2 boards, Novogene, Transjing Life, Jiete Biotech, Huaren Pharmaceuticals, and Nearshore Protein 20cm daily limit. According to the news, on September 18, ten departments including the Ministry of Industry and Information Technology jointly issued the "Fifteenth Five-Year Plan for the Development of the Pharmaceutical Industry". The plan proposes to accelerate the research and development of new technologies such as artificial intelligence, quantum computing, supercomputing, and computational medicine to empower drugs.